Allozyne, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
Allozyne, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					          Allozyne, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
       Reference Code: GDPH135285D                                                                                                            Publication Date: APR 2013

      Company Overview                                                                                        Key Facts
      Allozyne, Inc. (Allozyne) is a pharmaceutical and healthcare service providing
                                                                                                              Allozyne, Inc., Pharmaceuticals & Healthcare, Key
      company, based in the US. It develops protein-based therapeutics. The company
                                                                                                              Facts
      offers research and development, platform, pipeline and therapeutic focus. It
      commercializes proprietary Biociphering technology that it licensed from the                             Web Address                        www.allozyne.com
      California Institute of Technology. Allozyne’s product candidate includes AZ01, a
                                                                                                               Revenue (US$ million)                             NA
      Phase 1b clinical trial product for the treatment of relapsing-remitting multiple
      sclerosis. It also develops AZ17, a bi-specific antibody for the treatment of various                    Number of Employees                               NA
      autoimmune and inflammatory diseases. The company was established in the year                            GlobalData
      2004.

      Financial Deals Landscape
        Allozyne, Inc., Pharmaceuticals & Healthcare, Deals by Type,                      Allozyne, Inc., Pharmaceuticals & Healthcare, Deals By
        2007 to YTD 2013                                                                  Year, 2007 to YTD 2013


                                                                                                                                          2                2
                                                                                                          2




                                                                                           No. of Deals
                                                                                                                 1                                                   1
                                                                                                          1


                                                                                                                          0         0             0
                                                                                                          0
                                                                                                               2007      2008    2009    2010    2011     2012   YTD
                                                                                                                                                                 2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Allozyne, Inc., Pharmaceuticals & Healthcare, Deals By                           Allozyne, Inc., Pharmaceuticals & Healthcare, Deals By
         Region, 2007 to YTD 2013                                                         Therapy Area, 2007 to YTD 2013

                         8                                                                                6          5
                               6
          No. of Deals




                                                                                           No. of Deals




                                                                                                          5                     4
                         6
                                                                                                          4                               3           3
                         4
                                                                                                          3
                         2              1         1        1         1                                    2                                                      1
                         0                                                                                1
                             North    Asia-     Europe   Middle   South                                   0
                             Americ   Pacific             East     and                                          Central       Immun     Dermat    Oncolo Metabol
                               a                          and     Central                                       Nervou         ology     ology      gy      ic
                                                         Africa   Americ                                          s                                      Disorde
                                                                    a                                           System                                      rs



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




Allozyne, Inc. - Pharmaceuticals & Healthcare - Deals and                                                                                        Reference Code: GDPH135285D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                 Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Allozyne, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ............................................................................ 4
       Allozyne, Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ............................................................................. 5
       Allozyne, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ........................................................................ 6
       Allozyne, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 .............................................................. 7
       Allozyne, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013.......................................................................... 8
       Allozyne, Inc., Pharmaceuticals & Healthcare, Deal Details ............................................................................................................... 9
          Venture Financing........................................................................................................................................................................... 9
             Allozyne Raises US$1 Million In Venture Financing Round ........................................................................................................ 9
             Allozyne Raises $2 Million In Venture Financing....................................................................................................................... 10
             Allozyne Raises $2.5 Million In Venture Financing.................................................................................................................... 11
             Allozyne Secures $30 Million In Series B Financing ................................................................................................................. 12
          Licensing Agreements .................................................................................................................................................................. 14
             Allozyne Enters Into Licensing Agreement With Sigma-Aldrich ................................................................................................ 14
             Allozyne Enters Into Licensing Agreement With The Scripps Research Institute ...................................................................... 15
       Allozyne, Inc. - Key Comp
				
DOCUMENT INFO
Description: Allozyne, Inc. (Allozyne) is a pharmaceutical and healthcare service providing company, based in the US. It develops protein-based therapeutics. The company offers research and development, platform, pipeline and therapeutic focus. It commercializes proprietary Biociphering technology that it licensed from the California Institute of Technology. Allozyne’s product candidate includes AZ01, a Phase 1b clinical trial product for the treatment of relapsing-remitting multiple sclerosis. It also develops AZ17, a bi-specific antibody for the treatment of various autoimmune and inflammatory diseases. The company was established in the year 2004. Allozyne is headquartered in Seattle, Washington, the US.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.